Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
Conditions
Brief summary
This study is conducted in the Middle East, Northern Africa and Europe. The aim of this study is to contribute to the design of a simple screening strategy for countries in scope, by exploring the association between risk factors and undiagnosed diabetes in a screening study.
Interventions
OTHERNo treatment given
The screening test includes a combination of a risk assessment questionnaire and biochemical tests.
Sponsors
Novo Nordisk A/S
Study design
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* Informed consent obtained
Exclusion criteria
* Subjects with known diabetes (exception: women with a history of gestational diabetes should not be excluded) * Pregnant women or women who have given birth within less than a month * Subjects suffering from severe illness * Subjects with the inability to read and understand the information given (either due to illiteracy or vision problems) and therefore unable to give an informed consent * Subjects with mental impairment * Subjects treated with systemic cortico-steroids
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HbA1c (Glycosylated Haemoglobin) level | measured at the screening visit (only 1 visit during the 2 weeks stay of the bus in each country) |
Secondary
| Measure | Time frame |
|---|---|
| Number of subjects with diabetes (type 1 and 2) | measured at the screening visit (only 1 visit during the 2 weeks stay of the bus in each country) |
| The presence of retinopathy | measured at the screening visit (only 1 visit during the 2 weeks stay of the bus in each country) |
Countries
Portugal, Saudi Arabia, United Arab Emirates
Outcome results
None listed